Skip navigation
Home
Menu
Menu
Study
Student life
Research and innovation
Global
About us
Staff
Students
Search the site
Centre of Excellence for Long-acting Therapeutics
Menu
About us
LONGEVITY
HALo
Nanotherapeutics Hub
Teoreler
PKRxiv
LAPaL
Blog
News
Events
Contact us
News
New data from phase 3 SOLARIS results demonstrating patient and healthcare professional with a once-monthly subcutaneous long-acting injectable
09 May 2025
New study highlights monthly SUBLOCADE® as a potential treatment option for opioid use disorder during and after pregnancy
09 May 2025
Persons living with HIV can be treated safely, effectively with long-acting antiretroviral therapy at home
09 May 2025
Astria Therapeutics Announces Publication of Navenibart Phase 1a Healthy Subject Results in the Annals of Allergy, Asthma & Immunology
09 May 2025
Pacira BioSciences announces two-year efficacy data following a single local administration of PCRX-201 in patients with osteoarthritis of the knee
01 May 2025
New single-shot vaccine could offer controlled release of multiple doses over six months
01 May 2025
Insights into the hepatitis C drug market growth projections from 2024 to 2035
17 April 2025
CHAI's 2025 HIV Market Impact Memo highlights significant risks to HIV service delivery following reductions in US foreign aid.
17 April 2025
Luye Pharma announces U.S. launch of ERZOFRI® extended-release injectable suspension for the treatment of schizophrenia and schizoaffective disorder
11 April 2025
New data strengthens Teva’s schizophrenia portfolio, including phase 3 SOLARIS trial survey demonstrating patient and healthcare professional satisfaction
04 April 2025
News
New data from phase 3 SOLARIS results demonstrating patient and healthcare professional with a once-monthly subcutaneous long-acting injectable
09 May 2025
New study highlights monthly SUBLOCADE® as a potential treatment option for opioid use disorder during and after pregnancy
09 May 2025
Persons living with HIV can be treated safely, effectively with long-acting antiretroviral therapy at home
09 May 2025
Astria Therapeutics Announces Publication of Navenibart Phase 1a Healthy Subject Results in the Annals of Allergy, Asthma & Immunology
09 May 2025
Pacira BioSciences announces two-year efficacy data following a single local administration of PCRX-201 in patients with osteoarthritis of the knee
01 May 2025
New single-shot vaccine could offer controlled release of multiple doses over six months
01 May 2025
Insights into the hepatitis C drug market growth projections from 2024 to 2035
17 April 2025
Older Stories
.jpg)
.jpg)
.jpg)
.jpg)
